CMIC Holdings Co. Ltd. | Key People and Executives
Kazuo Nakamura
Chairman & Chief Executive Officer
Keiko Oishi
President, COO & Representative Director
Wataru Mochizuki
CFO, Director & Head-Internal Control
Nobuaki Inoue
Representative Director & Chief Technology Officer
Akihisa Mitake
Director & Senior Managing Executive Officer
Philippe Auvaro
Director & Senior Managing Executive Officer
Toru Fujieda
Director & Senior Managing Executive Officer
Makoto Matsukawa
Director & Senior Managing Executive Officer
Keiko Nakamura
Representative Director & Executive Vice President
Yoshiyuki Hano
Director & Chief Human Resource Officer
Masaru Iwasaki
Independent Director
Shinji Kobayashi
Independent Director
Akira Nakamura
Independent Director
Kazuo Nakamura
Chairman & Chief Executive Officer
Keiko Oishi
President, COO & Representative Director
Wataru Mochizuki
CFO, Director & Head-Internal Control
Nobuaki Inoue
Representative Director & Chief Technology Officer
Tetsuya Kawa
Managing Executive Officer
Akihisa Mitake
Director & Senior Managing Executive Officer
Philippe-Henri Auvaro
Director & Senior Managing Executive Officer
Toru Fujieda
Director & Senior Managing Executive Officer
Makoto Matsukawa
Director & Senior Managing Executive Officer
Keiko Nakamura
Representative Director & Executive Vice President
Eiji Sakou
Head-Audit & Compliance
Yoshiyuki Hano
Director & Chief Human Resource Officer
Tetsuyoshi Takamoto
Auditor
Takashi Sano
Senior Managing Executive Officer
Masaya Kato
Executive Officer & Head-Legal Affairs
Masaru Iwasaki
Independent Director
Shinji Kobayashi
Independent Director
Akira Nakamura
Independent Director
| Address |
Hamamatsucho Building
Tokyo Tokyo 105
Japan
|
|
Employees
|
- |
| Website |
http://www.cmic-holdings.co.jp |
| Updated |
07/08/2019 |
| CMIC Holdings Co., Ltd. engages in the provision of support services for pharmaceutical development, manufacturing, and sales. Its operations are carried out through the following segments: Contract Research Organization (CRO), Contract Manufacturing Organization (CMO), Contract Sales Organization (CSO), Health Care, and Intellectual Properties Development (IPD). The CRO segment provides the professional services related to the administration of clinical study and survey upon manufacture and sale such as monitoring, data management, pharmaceutical consulting, and preclinical businesses. |
